The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | J | Antiinfectives for systemic use | |
| 2 | J07 | Vaccines | |
| 3 | J07B | Viral vaccines | |
| 4 | J07BX | Other viral vaccines | |
| 5 | J07BX05 |
| Active Ingredient | Description | |
|---|---|---|
| RSV glycoprotein F antigen |
RSV glycoprotein F antigen is designed to enhance antigen-specific cellular immune response and neutralizing antibodies response in individuals with pre-existing immunity against RSV. The adjuvant AS01E facilitates the recruitment and activation of antigen presenting cells carrying vaccine-derived antigens in the draining lymph node, which in turn leads to the generation of RSVPreF3-specific CD4+ T cells. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| ABRYSVO Powder and solvent for solution for injection | European Medicines Agency (EU) | MPI, EU: SmPC | |
| AREXVY Powder for suspension for injection | European Medicines Agency (EU) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
